Literature DB >> 33169143

The apelin/APJ system in the regulation of vascular tone: friend or foe?

Yoshiyuki Rikitake1.   

Abstract

The apelin (APJ) receptor was originally cloned as a gene encoding a putative G protein-coupled receptor related to angiotensin receptor type I. To date, two endogenous peptide ligands for APJ have been identified: apelin and elabela/Toddler. The apelin/APJ system regulates blood pressure and vascular tone. The endothelial and smooth muscle apelin/APJ systems exert opposite actions in the regulation of vascular tone. Binding of apelin to endothelial APJ promotes the release of vasodilators, such as nitric oxide and prostacyclin, leading to vasodilation. Alternatively, binding of apelin to smooth muscle APJ induces vasoconstriction, although the molecular mechanisms of the apelin-induced vasoconstriction are poorly understood. Recently, a critical role for interaction of APJ with α1-adrenergic receptor in the apelin-induced vasoconstriction was reported. The action of apelin on vascular tone may depend upon blood vessel type or pathological condition. Although the apelin/APJ system could serve as a potential therapeutic target for hypertension and cardiovascular disease, the role of this system in various cell types appears to be complicated.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  APJ; G protein-coupled; apelin; blood pressure; vascular smooth muscle

Mesh:

Substances:

Year:  2021        PMID: 33169143     DOI: 10.1093/jb/mvaa129

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

Review 1.  The pleiotropic roles of adipocyte secretome in remodeling breast cancer.

Authors:  Xiaomei Zhou; Jun Zhang; Wenchang Lv; Chongru Zhao; Yu Xia; Yiping Wu; Qi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

Review 2.  The Role of Apelin-APJ System in Diabetes and Obesity.

Authors:  Cheng Li; Hongna Cheng; Binay Kumar Adhikari; Shudong Wang; Na Yang; Wenyun Liu; Jian Sun; Yonggang Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.